Dynavax Technologies 8-K Filing: Key Corporate Update on January 13, 2025

$DVAX
Form 8-K
Filed on: 2025-01-13
Source
Dynavax Technologies 8-K Filing: Key Corporate Update on January 13, 2025

Based on the provided section of the financial report, here are the key pieces of information extracted:

  1. Entity Information:
  • Company Name: Dynavax Technologies Corporation
  • CIK Number: 0001029142
  • SEC Central Index Key (CIK): This number is unique and helps identify the company in SEC filings.
  1. Filing Details:
  • Form Type: 8-K (a report of unscheduled material events or corporate changes that are of importance to shareholders)
  • Filing Date: January 13, 2025
  1. Business Location:
  • Address: 2100 Powell Street, Suite 720, Emeryville, CA 94608
  • Phone Number: 510-848-5100
  1. Stock Information:
  • Common Stock Par Value: $0.001
  • Ticker Symbol: DVAX
  • Exchange: NASDAQ
  1. Period of Reporting:
  • Start Date: January 13, 2025
  • End Date: January 13, 2025

Insights:

  • The filing indicates a specific event or change that Dynavax Technologies Corporation deemed significant enough to report to the SEC. As an 8-K filing, it typically covers material events that could affect the company's financial position or operations.
  • The document is structured in XBRL format, which is used for electronic submissions to the SEC, indicating adherence to standardized reporting practices.
  • The company is identified with a clear unique identifier (CIK), which is essential for tracking its filings and financial health over time.

Overall, this entry suggests that investors should review the associated 8-K filing for potential impacts on the company's stock performance or operational changes.